Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Millennium and Lilly extend cardiovascular research collaboration

Oct. 7, 1997

No Comments

HMR and Andrx agree to stipulation in Cardizem CD patent lawsuit

Oct. 7, 1997

No Comments

Cytokine synthesis inhibitor protects against polymicrobial sepsis in animal model

Oct. 6, 1997

No Comments

Novel class III antiarrhythmic agents described by Merck & Co.

Oct. 6, 1997

No Comments

Cypros to start phase III trial for CABG

Oct. 3, 1997

No Comments

Focus on benzoyl guanidines as Na+/H+-exchange inhibitors

Oct. 2, 1997

No Comments

Cytel reports encouraging results from Cylexin phase I/II trial

Oct. 2, 1997

No Comments

Single- and multiple-dose clinical studies reported for SL-91.0102

Oct. 1, 1997

No Comments

New treatment for ISH evaluated in humans

Oct. 1, 1997

No Comments

Na+/K+-exchange inhibitors from Fujisawa

Sep. 30, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Cardiovascular
RSS

Millennium and Lilly extend cardiovascular research collaboration

HMR and Andrx agree to stipulation in Cardizem CD patent lawsuit

Cytokine synthesis inhibitor protects against polymicrobial sepsis in animal model

Novel class III antiarrhythmic agents described by Merck & Co.

Cypros to start phase III trial for CABG

Focus on benzoyl guanidines as Na+/H+-exchange inhibitors

Cytel reports encouraging results from Cylexin phase I/II trial

Single- and multiple-dose clinical studies reported for SL-91.0102

New treatment for ISH evaluated in humans

Na+/K+-exchange inhibitors from Fujisawa

Today's news in brief

Today's news in brief

Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance

Australia’s Celosia heads toward clinic with gene therapy for ALS

Sangamo stock plunges as Pfizer leaves hemophilia partnership

Cardiovascular RSS

Cardiovascular
RSS